Your trusted source for clinical AI tools, research breakthroughs, and real-world applications transforming patient care.
A ranked readout of the pages carrying the strongest current coverage signal across AI Medicine Now, including new governance, release, inspection, ambient documentation, and specialty workflow guides.
Hospitals should not evaluate clinical AI vendors like ordinary software purchases. The right process starts with a defined clinical problem, then moves through evidence, regulatory status, workflow fit, privacy, governance, contracting, and post-deployment monitoring.
Clinical AI implementation is the work of translating a promising use case into a safe, usable, and monitorable part of care delivery. Hospitals need more than a vendor demo. They need readiness, governance, workflow design, integration discipline, training, monitoring, and a clear decision path from pilot to scale.
Use this clinical AI procurement scorecard to flag review gaps before a hospital signs a vendor contract, starts a pilot, or expands a clinical AI tool.
Evaluate an AI diagnostic platform by intended use, evidence, regulatory status, workflow fit, privacy, integration, monitoring, governance, and commercial risk.
AI product release criteria help health systems and vendors decide whether a clinical AI tool is ready for pilot, go-live, expansion, or re-release after a model or workflow change.
Structured coverage across the five core domains of AI medicine.
Direct patient-care AI for diagnosis, decision support, treatment planning, specialties, regulation, implementation, and adoption.
ExploreArtificial intelligence in radiology, imaging modalities, workflow, validation, vendors, implementation, and enterprise deployment.
ExploreAI physician workflow tools should reduce documentation and administrative friction while preserving review, privacy, and accountability.
ExploreClinical studies, FDA activity, medical AI research, genomics, drug discovery, and precision medicine.
ExploreAI product release criteria help health systems and vendors decide whether a clinical AI tool is ready for pilot, go-live, expansion, or re-release after a model or workflow change.
AI in independent medical exams may support record review, chronology building, documentation, consistency checks, and administrative workflow, but physician independence, privacy, accuracy, and disclosure remain central.
Ambient AI and traditional medical scribes both reduce documentation burden, but they create different review, privacy, workflow, accuracy, training, and vendor-governance questions.
A clinical AI inventory helps health systems know which AI tools are in use, who owns them, what data they touch, what evidence supports them, and what monitoring is required after deployment.
FDA inspection readiness for AI-enabled clinical software is mainly quality-system readiness: intended use, design controls, software validation, risk management, change control, complaints, CAPA, labeling, and lifecycle records.
Clinical AI governance is usually discussed at the model, vendor, and workflow levels. But hospitals also need to govern the infrastructure below the application layer: data locality, uptime, access, logs, monitoring, recovery, and system change.
Three specialized resources covering the full spectrum of AI in healthcare.